Back to trial details

Intake questionnaire

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Applying to UNC Chapel Hill · Chapel Hill, North Carolina

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 65 years old?
2. Have you been diagnosed with Systemic Lupus Erythematosus?
3. Are you able to travel to Chapel Hill for study visits?